Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 09:01 am Sale | 2021-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -892,555 (Position Closed) | Filing History |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | ELEDON PHARMACEUTICALS INC ELDN | FMR LLC | 504,371 3.525% | -499,740 (-49.77%) | Filing History |
| 2022-01-28 4:35 pm Purchase | 2022-01-20 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% | 878,690 (+60.68%) | Filing History |
| 2022-01-26 4:27 pm Sale | 2022-01-20 | 13G | ELEDON PHARMACEUTICALS INC ELDN | Logos Global Management LP | 0 0.000% | -1,339,793 (Position Closed) | Filing History |
| 2022-01-10 5:57 pm Purchase | 2022-01-06 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% | 13,088 (+0.91%) | Filing History |
| 2022-01-10 5:51 pm Sale | 2021-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% | -68,189 (-4.54%) | Filing History |
| 2021-09-09 12:30 pm Purchase | 2020-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | Logos Global Management LP | 1,339,793 9.400% | 1,115,722 (+497.93%) | Filing History |